First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia

Neisseria meningitidis is one of the leading causes of bacterial meningitis and sepsis in Croatia. Meningococcal strains with decreased susceptibility to penicillin (MIC > 0.12 mg/ml) have been reported worldwide since 1985. Here we report the first identification of an isolate intermediately res...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical microbiology 2001-02, Vol.39 (2), p.823-823
Hauptverfasser: Boras, A, Bozinovic, D, Tenover, F C, Popovic, T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 823
container_issue 2
container_start_page 823
container_title Journal of clinical microbiology
container_volume 39
creator Boras, A
Bozinovic, D
Tenover, F C
Popovic, T
description Neisseria meningitidis is one of the leading causes of bacterial meningitis and sepsis in Croatia. Meningococcal strains with decreased susceptibility to penicillin (MIC > 0.12 mg/ml) have been reported worldwide since 1985. Here we report the first identification of an isolate intermediately resistant to penicillin in Croatia. An 8-month-old male child presented to the Emergency Department at University Hospital for Infectious Diseases, Zagreb, Croatia, with a 2-day history of fever (>39 degree C). The child was somnolent, with characteristic meningeal signs and petechia on its scrotum and entire extremities. The white blood cell count was 5,800/mm super(3), with 51 segmented neutrophils and 32 lymphocytes. The cerebrospinal fluid (CSF) contained 92,416 cells/mm super(3), the protein concentration was 2,040 mg/liter, and the glucose concentration was 0.3 mmol/liter. Gram-negative diplococci were visible on a Gram-stained smear, and latex agglutination performed on the CSF was positive for N. meningitidis serogroup B (Slidex meningite-Kit 5; bioMerieux, Marcy-l'Etoile, France). Ceftriaxone therapy was instituted, and household contacts were treated with rifampin.
doi_str_mv 10.1128/JCM.39.2.823.2001
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_87832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17809995</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-957a218454157f1628a1c5f451ec4a96ab939f8d954e48cb107835da125dd1773</originalsourceid><addsrcrecordid>eNpVkU1LAzEQhoMotlZ_gBfZk7ddM8mmm4AXKdYPql4UegvpbraObDc1SQX_vSkWPw5DDvM8k2FeQk6BFgBMXtxPHgquClZIxgtGKeyRIVAl8_GYzvfJkFIlcgBeDchRCG8JKEshDslga6eiQzKfog8x83btfMxcmz1aDMF6NNnK9tgvMWKDIcM-Wr-yDZpou8_EBwzR9DGLLlsnsMauwz5h2cQ7E9Eck4PWdMGe7N4ReZleP09u89nTzd3kapbXXPGYK1EZBrIUJYiqhTGTBmrRlgJsXRo1NgvFVSsbJUpbynoBtJJcNAaYaBqoKj4il99z15tF2q-2ffSm02uPK-M_tTOo_3d6fNVL96FlGsSSfr7TvXvf2BD1CkNtu8701m2ChkpSpZRIIHyDtXcheNv-fAFUb--pUxqaK810SkNv00jO2d_dfo3d-fkXWH-H2w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17809995</pqid></control><display><type>article</type><title>First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia</title><source>American Society for Microbiology</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Boras, A ; Bozinovic, D ; Tenover, F C ; Popovic, T</creator><creatorcontrib>Boras, A ; Bozinovic, D ; Tenover, F C ; Popovic, T</creatorcontrib><description>Neisseria meningitidis is one of the leading causes of bacterial meningitis and sepsis in Croatia. Meningococcal strains with decreased susceptibility to penicillin (MIC &gt; 0.12 mg/ml) have been reported worldwide since 1985. Here we report the first identification of an isolate intermediately resistant to penicillin in Croatia. An 8-month-old male child presented to the Emergency Department at University Hospital for Infectious Diseases, Zagreb, Croatia, with a 2-day history of fever (&gt;39 degree C). The child was somnolent, with characteristic meningeal signs and petechia on its scrotum and entire extremities. The white blood cell count was 5,800/mm super(3), with 51 segmented neutrophils and 32 lymphocytes. The cerebrospinal fluid (CSF) contained 92,416 cells/mm super(3), the protein concentration was 2,040 mg/liter, and the glucose concentration was 0.3 mmol/liter. Gram-negative diplococci were visible on a Gram-stained smear, and latex agglutination performed on the CSF was positive for N. meningitidis serogroup B (Slidex meningite-Kit 5; bioMerieux, Marcy-l'Etoile, France). Ceftriaxone therapy was instituted, and household contacts were treated with rifampin.</description><identifier>ISSN: 0095-1137</identifier><identifier>EISSN: 1098-660X</identifier><identifier>DOI: 10.1128/JCM.39.2.823.2001</identifier><identifier>PMID: 11281120</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>ceftriaxone ; Ceftriaxone - therapeutic use ; Cephalosporins - therapeutic use ; Cortisone - therapeutic use ; Croatia ; Humans ; Infant ; Letters to the Editor ; Male ; Meningitis, Meningococcal - diagnosis ; Meningitis, Meningococcal - drug therapy ; Microbial Sensitivity Tests ; Neisseria meningitidis ; Neisseria meningitidis - classification ; Neisseria meningitidis - drug effects ; Neisseria meningitidis - isolation &amp; purification ; penicillin ; Penicillin Resistance ; rifampin ; Treatment Outcome</subject><ispartof>Journal of clinical microbiology, 2001-02, Vol.39 (2), p.823-823</ispartof><rights>Copyright © 2001, American Society for Microbiology 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-957a218454157f1628a1c5f451ec4a96ab939f8d954e48cb107835da125dd1773</citedby><cites>FETCH-LOGICAL-c393t-957a218454157f1628a1c5f451ec4a96ab939f8d954e48cb107835da125dd1773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC87832/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC87832/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3186,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11281120$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boras, A</creatorcontrib><creatorcontrib>Bozinovic, D</creatorcontrib><creatorcontrib>Tenover, F C</creatorcontrib><creatorcontrib>Popovic, T</creatorcontrib><title>First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia</title><title>Journal of clinical microbiology</title><addtitle>J Clin Microbiol</addtitle><description>Neisseria meningitidis is one of the leading causes of bacterial meningitis and sepsis in Croatia. Meningococcal strains with decreased susceptibility to penicillin (MIC &gt; 0.12 mg/ml) have been reported worldwide since 1985. Here we report the first identification of an isolate intermediately resistant to penicillin in Croatia. An 8-month-old male child presented to the Emergency Department at University Hospital for Infectious Diseases, Zagreb, Croatia, with a 2-day history of fever (&gt;39 degree C). The child was somnolent, with characteristic meningeal signs and petechia on its scrotum and entire extremities. The white blood cell count was 5,800/mm super(3), with 51 segmented neutrophils and 32 lymphocytes. The cerebrospinal fluid (CSF) contained 92,416 cells/mm super(3), the protein concentration was 2,040 mg/liter, and the glucose concentration was 0.3 mmol/liter. Gram-negative diplococci were visible on a Gram-stained smear, and latex agglutination performed on the CSF was positive for N. meningitidis serogroup B (Slidex meningite-Kit 5; bioMerieux, Marcy-l'Etoile, France). Ceftriaxone therapy was instituted, and household contacts were treated with rifampin.</description><subject>ceftriaxone</subject><subject>Ceftriaxone - therapeutic use</subject><subject>Cephalosporins - therapeutic use</subject><subject>Cortisone - therapeutic use</subject><subject>Croatia</subject><subject>Humans</subject><subject>Infant</subject><subject>Letters to the Editor</subject><subject>Male</subject><subject>Meningitis, Meningococcal - diagnosis</subject><subject>Meningitis, Meningococcal - drug therapy</subject><subject>Microbial Sensitivity Tests</subject><subject>Neisseria meningitidis</subject><subject>Neisseria meningitidis - classification</subject><subject>Neisseria meningitidis - drug effects</subject><subject>Neisseria meningitidis - isolation &amp; purification</subject><subject>penicillin</subject><subject>Penicillin Resistance</subject><subject>rifampin</subject><subject>Treatment Outcome</subject><issn>0095-1137</issn><issn>1098-660X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU1LAzEQhoMotlZ_gBfZk7ddM8mmm4AXKdYPql4UegvpbraObDc1SQX_vSkWPw5DDvM8k2FeQk6BFgBMXtxPHgquClZIxgtGKeyRIVAl8_GYzvfJkFIlcgBeDchRCG8JKEshDslga6eiQzKfog8x83btfMxcmz1aDMF6NNnK9tgvMWKDIcM-Wr-yDZpou8_EBwzR9DGLLlsnsMauwz5h2cQ7E9Eck4PWdMGe7N4ReZleP09u89nTzd3kapbXXPGYK1EZBrIUJYiqhTGTBmrRlgJsXRo1NgvFVSsbJUpbynoBtJJcNAaYaBqoKj4il99z15tF2q-2ffSm02uPK-M_tTOo_3d6fNVL96FlGsSSfr7TvXvf2BD1CkNtu8701m2ChkpSpZRIIHyDtXcheNv-fAFUb--pUxqaK810SkNv00jO2d_dfo3d-fkXWH-H2w</recordid><startdate>20010201</startdate><enddate>20010201</enddate><creator>Boras, A</creator><creator>Bozinovic, D</creator><creator>Tenover, F C</creator><creator>Popovic, T</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20010201</creationdate><title>First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia</title><author>Boras, A ; Bozinovic, D ; Tenover, F C ; Popovic, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-957a218454157f1628a1c5f451ec4a96ab939f8d954e48cb107835da125dd1773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>ceftriaxone</topic><topic>Ceftriaxone - therapeutic use</topic><topic>Cephalosporins - therapeutic use</topic><topic>Cortisone - therapeutic use</topic><topic>Croatia</topic><topic>Humans</topic><topic>Infant</topic><topic>Letters to the Editor</topic><topic>Male</topic><topic>Meningitis, Meningococcal - diagnosis</topic><topic>Meningitis, Meningococcal - drug therapy</topic><topic>Microbial Sensitivity Tests</topic><topic>Neisseria meningitidis</topic><topic>Neisseria meningitidis - classification</topic><topic>Neisseria meningitidis - drug effects</topic><topic>Neisseria meningitidis - isolation &amp; purification</topic><topic>penicillin</topic><topic>Penicillin Resistance</topic><topic>rifampin</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boras, A</creatorcontrib><creatorcontrib>Bozinovic, D</creatorcontrib><creatorcontrib>Tenover, F C</creatorcontrib><creatorcontrib>Popovic, T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boras, A</au><au>Bozinovic, D</au><au>Tenover, F C</au><au>Popovic, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia</atitle><jtitle>Journal of clinical microbiology</jtitle><addtitle>J Clin Microbiol</addtitle><date>2001-02-01</date><risdate>2001</risdate><volume>39</volume><issue>2</issue><spage>823</spage><epage>823</epage><pages>823-823</pages><issn>0095-1137</issn><eissn>1098-660X</eissn><abstract>Neisseria meningitidis is one of the leading causes of bacterial meningitis and sepsis in Croatia. Meningococcal strains with decreased susceptibility to penicillin (MIC &gt; 0.12 mg/ml) have been reported worldwide since 1985. Here we report the first identification of an isolate intermediately resistant to penicillin in Croatia. An 8-month-old male child presented to the Emergency Department at University Hospital for Infectious Diseases, Zagreb, Croatia, with a 2-day history of fever (&gt;39 degree C). The child was somnolent, with characteristic meningeal signs and petechia on its scrotum and entire extremities. The white blood cell count was 5,800/mm super(3), with 51 segmented neutrophils and 32 lymphocytes. The cerebrospinal fluid (CSF) contained 92,416 cells/mm super(3), the protein concentration was 2,040 mg/liter, and the glucose concentration was 0.3 mmol/liter. Gram-negative diplococci were visible on a Gram-stained smear, and latex agglutination performed on the CSF was positive for N. meningitidis serogroup B (Slidex meningite-Kit 5; bioMerieux, Marcy-l'Etoile, France). Ceftriaxone therapy was instituted, and household contacts were treated with rifampin.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>11281120</pmid><doi>10.1128/JCM.39.2.823.2001</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0095-1137
ispartof Journal of clinical microbiology, 2001-02, Vol.39 (2), p.823-823
issn 0095-1137
1098-660X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_87832
source American Society for Microbiology; MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects ceftriaxone
Ceftriaxone - therapeutic use
Cephalosporins - therapeutic use
Cortisone - therapeutic use
Croatia
Humans
Infant
Letters to the Editor
Male
Meningitis, Meningococcal - diagnosis
Meningitis, Meningococcal - drug therapy
Microbial Sensitivity Tests
Neisseria meningitidis
Neisseria meningitidis - classification
Neisseria meningitidis - drug effects
Neisseria meningitidis - isolation & purification
penicillin
Penicillin Resistance
rifampin
Treatment Outcome
title First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A04%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=First%20report%20of%20Neisseria%20meningitidis%20intermediately%20resistant%20to%20penicillin%20in%20Croatia&rft.jtitle=Journal%20of%20clinical%20microbiology&rft.au=Boras,%20A&rft.date=2001-02-01&rft.volume=39&rft.issue=2&rft.spage=823&rft.epage=823&rft.pages=823-823&rft.issn=0095-1137&rft.eissn=1098-660X&rft_id=info:doi/10.1128/JCM.39.2.823.2001&rft_dat=%3Cproquest_pubme%3E17809995%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17809995&rft_id=info:pmid/11281120&rfr_iscdi=true